297 related articles for article (PubMed ID: 31925721)
1. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
Salehifar E; Janbabaei G; Hendouei N; Alipour A; Tabrizi N; Avan R
Clin Drug Investig; 2020 Mar; 40(3):249-257. PubMed ID: 31925721
[TBL] [Abstract][Full Text] [Related]
2. The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial.
Avan R; Janbabaei G; Hendouei N; Alipour A; Borhani S; Tabrizi N; Salehifar E
J Res Med Sci; 2018; 23():52. PubMed ID: 30057636
[TBL] [Abstract][Full Text] [Related]
3. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
4. Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
Barohn RJ; Gajewski B; Pasnoor M; Brown A; Herbelin LL; Kimminau KS; Mudaranthakam DP; Jawdat O; Dimachkie MM; ; Iyadurai S; Stino A; Kissel J; Pascuzzi R; Brannagan T; Wicklund M; Ahmed A; Walk D; Smith G; Quan D; Heitzman D; Tobon A; Ladha S; Wolfe G; Pulley M; Hayat G; Li Y; Thaisetthawatkul P; Lewis R; Biliciler S; Sharma K; Salajegheh K; Trivedi J; Mallonee W; Burns T; Jacoby M; Bril V; Vu T; Ramchandren S; Bazant M; Austin S; Karam C; Hussain Y; Kutz C; Twydell P; Scelsa S; Kushlaf H; Wymer J; Hehir M; Kolb N; Ralph J; Barboi A; Verma N; Ahmed M; Memon A; Saperstein D; Lou JS; Swenson A; Cash T
JAMA Neurol; 2021 Jan; 78(1):68-76. PubMed ID: 32809014
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Gül ŞK; Tepetam H; Gül HL
Brain Behav; 2020 Mar; 10(3):e01527. PubMed ID: 31967742
[TBL] [Abstract][Full Text] [Related]
6. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Preoperative Administration of Pregabalin and Duloxetine on Cognitive Functions and Pain Management After Spinal Surgery: A Randomized, Double-blind, Placebo-controlled Study.
Altiparmak B; Güzel Ç; Gümüş Demirbilek S
Clin J Pain; 2018 Dec; 34(12):1114-1120. PubMed ID: 30020088
[TBL] [Abstract][Full Text] [Related]
8. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.
Matsuoka H; Clark K; Fazekas B; Oyamada S; Brown L; Ishiki H; Matsuda Y; Hasuo H; Ariyoshi K; Lee J; Le B; Allcroft P; Kochovska S; Fujiwara N; Miyaji T; Lovell M; Agar M; Yamaguchi T; Satomi E; Iwase S; Phillips J; Koyama A; Currow DC
BMJ Open; 2022 Feb; 12(2):e050182. PubMed ID: 35131817
[TBL] [Abstract][Full Text] [Related]
9. A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy.
Majdinasab N; Kaveyani H; Azizi M
Drug Des Devel Ther; 2019; 13():1985-1992. PubMed ID: 31354243
[No Abstract] [Full Text] [Related]
10. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
Smith EM; Pang H; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Fadul CE; Knox C; Le-Lindqwister N; Gilman PB; Shapiro CL;
JAMA; 2013 Apr; 309(13):1359-67. PubMed ID: 23549581
[TBL] [Abstract][Full Text] [Related]
11. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
[TBL] [Abstract][Full Text] [Related]
12. Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
Irving G; Tanenberg RJ; Raskin J; Risser RC; Malcolm S
Int J Clin Pract; 2014 Sep; 68(9):1130-40. PubMed ID: 24837444
[TBL] [Abstract][Full Text] [Related]
13. Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Shinomiya T; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Matsuda Y; Morita T; Koyama A; Yamaguchi T
J Pain Symptom Manage; 2019 Oct; 58(4):645-653. PubMed ID: 31254640
[TBL] [Abstract][Full Text] [Related]
14. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Julious S; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude EB; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Rice ASC; Bouhassira D; Bennett DL; Selvarajah D;
Lancet; 2022 Aug; 400(10353):680-690. PubMed ID: 36007534
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Efficacy of Duloxetine and Pregabalin in Pain Relief Associated with Diabetic Neuropathy.
Shahid W; Kumar R; Shaikh A; Kumar S; Jameel R; Fareed S
Cureus; 2019 Jul; 11(7):e5293. PubMed ID: 31579634
[TBL] [Abstract][Full Text] [Related]
16. Taxane-induced peripheral neuropathy and quality of life in breast cancer patients.
Salehifar E; Janbabaei G; Alipour A; Tabrizi N; Avan R
J Oncol Pharm Pract; 2020 Sep; 26(6):1421-1428. PubMed ID: 31937190
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
19. Fixed dose combination of low dose pregabalin and duloxetine, or pregabalin monotherapy for neuropathic pain: A double-blind, randomized, parallel-group study.
K K; Dutt S; Rattan P; Dadhania A; Gupta R; Joshi D; Kakkad A; Makwana A; Jha P
F1000Res; 2023; 12():353. PubMed ID: 38618021
[No Abstract] [Full Text] [Related]
20. Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Rheumatol Int; 2016 May; 36(5):663-72. PubMed ID: 27000046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
